| A Multinational Survey of Risk Factors for Infection with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Nonhospitalized Patients R Ben-Ami, J Rodríguez-Baño, H Arslan, JDD Pitout, C Quentin, ES Calbo, ... Clinical Infectious Diseases 49 (5), 682-690, 2009 | 645 | 2009 |
| Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey H Arslan, ÖK Azap, Ö Ergönül, F Timurkaynak Journal of Antimicrobial Chemotherapy 56 (5), 914-918, 2005 | 430 | 2005 |
| In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated … F Timurkaynak, F Can, ÖK Azap, M Demirbilek, H Arslan, SÖ Karaman International journal of antimicrobial agents 27 (3), 224-228, 2006 | 300 | 2006 |
| Risk factors for extended-spectrum β-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections ÖK Azap, H Arslan, K Şerefhanoğlu, Ş Çolakoğlu, H Erdoğan, ... Clinical microbiology and infection 16 (2), 147-151, 2010 | 284 | 2010 |
| A comparative analysis of tuberculous, brucellar and pyogenic spontaneous spondylodiscitis patients T Turunc, YZ Demiroglu, H Uncu, S Colakoglu, H Arslan Journal of infection 55 (2), 158-163, 2007 | 220 | 2007 |
| Effectiveness of human amnion preserved long-term in glycerol as a temporary biological dressing T Maral, H Borman, H Arslan, B Demirhan, G Akinbingol, M Haberal Burns 25 (7), 625-635, 1999 | 163 | 1999 |
| The Relationship of ABO Blood Group, Age, Gender, Smoking, and Helicobacter pylori Infection M Kanbay, G Gür, H Arslan, U Yilmaz, S Boyacioĝlu Digestive diseases and sciences 50, 1214-1217, 2005 | 160 | 2005 |
| Does Eradication of Helicobacter pylori Infection Help Normalize Serum Lipid and CRP Levels? M Kanbay, G Gür, H Arslan, U Yilmaz, S Boyacioĝlu Digestive diseases and sciences 50, 1228-1231, 2005 | 149 | 2005 |
| Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit P Dursun, SS Senger, H Arslan, E Kuşçu, A Ayhan BMC infectious diseases 9, 1-6, 2009 | 146 | 2009 |
| Etiologic agents of diarrhea in solid organ recipients H Arslan, EK Inci, OK Azap, H Karakayali, A Torgay, M Haberal Transplant Infectious Disease 9 (4), 270-275, 2007 | 140 | 2007 |
| Osteoarticular involvement among 202 brucellosis cases identified in Central Anatolia region of Turkey H Turan, K Serefhanoglu, E Karadeli, T Togan, H Arslan Internal Medicine 50 (5), 421-428, 2011 | 94 | 2011 |
| Urinary tract infections in renal transplant recipients SS Senger, H Arslan, ÖK Azap, F Timurkaynak, Ü Çağır, M Haberal Transplantation proceedings 39 (4), 1016-1017, 2007 | 92 | 2007 |
| Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment M Gürsoy, G Gür, H Arslan, N Özdemir, S Boyacıogˇlu Journal of Viral Hepatitis 8 (1), 70-77, 2001 | 89 | 2001 |
| Emerging Escherichia coli O25b/ST131 Clone Predicts Treatment Failure in Urinary Tract Infections F Can, OK Azap, C Seref, P Ispir, H Arslan, O Ergonul Clinical Infectious Diseases 60 (4), 523-527, 2015 | 79 | 2015 |
| Bloodstream infections caused by ESBL-producing E. coli and K. pneumoniae: risk factors for multidrug-resistance K Serefhanoglu, H Turan, FE Timurkaynak, H Arslan Brazilian Journal of Infectious Diseases 13, 403-407, 2009 | 79 | 2009 |
| Brucellosis: retrospective evaluation of the clinical, laboratory and epidemiological features of 151 cases YZ Demiroğlu, T Turunc, H Alişkan, S Colakoğlu, H Arslan Mikrobiyoloji Bulteni 41 (4), 517-527, 2007 | 79 | 2007 |
| The prevalence, etiologic agents and risk factors for urinary tract infection among spinal cord injury patients T Togan, OK Azap, E Durukan, H Arslan Jundishapur journal of microbiology 7 (1), 2014 | 73 | 2014 |
| In vitro activity of fosfomycin in combination with imipenem, meropenem, colistin and tigecycline against OXA 48–positive Klebsiella pneumoniae strains E Evren, ÖK Azap, Ş Çolakoğlu, H Arslan Diagnostic microbiology and infectious disease 76 (3), 335-338, 2013 | 71 | 2013 |
| Incidence of inducible clindamycin resistance in staphylococci: first results from Turkey ÖK Azap, H Arslan, F Timurkaynak, G Yapar, E Oruc, Ü Gair Clinical microbiology and infection 11 (7), 582-584, 2005 | 68 | 2005 |
| Distribution of HCV genotypes in patients with end-stage renal disease according to type of dialysis treatment H Selcuk, M Kanbay, M Korkmaz, G Gur, A Akcay, H Arslan, N Ozdemir, ... Digestive diseases and sciences 51, 1420-1425, 2006 | 66 | 2006 |
